Graham P Taylor Selected Research

Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)

12/2022	Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P).
2/2021	Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019.
1/2017	Reducing the global burden of HTLV-1 infection: An agenda for research and action.
3/2016	Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.
1/2016	Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
12/2015	HTLV-1 viral RNA is detected rarely in plasma of HTLV-1 infected subjects.
1/2012	Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis.
10/2011	Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
1/2011	Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.
9/2006	Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Graham P Taylor Research Topics

Disease

20	Infections 10/2022 - 12/2003
14	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2019 - 09/2005
13	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 05/2002
7	Spinal Cord Diseases 11/2021 - 07/2003
6	Lymphoma (Lymphomas) 01/2019 - 12/2011
5	Coinfection 01/2022 - 10/2011
5	Inflammation (Inflammations) 11/2021 - 12/2003
5	Neoplasms (Cancer) 01/2020 - 12/2003
4	HIV Infections (HIV Infection) 10/2019 - 02/2014
3	Virus Diseases (Viral Diseases) 01/2018 - 07/2003
2	Human Influenza (Influenza) 10/2021 - 10/2019
2	Premature Birth (Birth, Premature) 01/2021 - 03/2014
2	Leukemia 01/2019 - 11/2016
2	Necrosis 01/2016 - 01/2016
2	Syphilis 02/2015 - 10/2011
2	Tuberculosis (Tuberculoses) 09/2013 - 01/2002
2	Ulcer 10/2011 - 10/2011
2	T-Cell Leukemia (Leukemia, T Cell) 05/2011 - 12/2003
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Asymptomatic Infections 01/2022
1	COVID-19 10/2021
1	Thrombosis (Thrombus) 10/2021
1	Rare Diseases (Rare Disease) 02/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Leukocytosis (Pleocytosis) 04/2018
1	Residual Neoplasm 03/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Lymphocytosis 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 12/2016
1	Pain (Aches) 01/2016
1	Disease Progression 12/2015
1	Opportunistic Infections (Opportunistic Infection) 09/2015
1	Anthrax 07/2014
1	Down Syndrome (Down's Syndrome) 02/2014
1	Latent Tuberculosis 09/2013
1	Multiple Sclerosis 01/2012

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 10/2021 - 12/2003
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2011
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2002
4	Zidovudine (Retrovir)FDA LinkGeneric 03/2018 - 09/2006
3	VaccinesIBA 10/2022 - 05/2005
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2013
3	Antiviral Agents (Antivirals)IBA 12/2012 - 07/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 02/2022
2	AntigensIBA 10/2022 - 09/2015
2	Methylprednisolone FDA LinkGeneric 02/2022 - 01/2016
2	AntibodiesIBA 12/2020 - 08/2005
2	mogamulizumabIBA 12/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 07/2011
2	InterferonsIBA 03/2018 - 01/2012
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2003
2	Interleukin-2 (IL2)IBA 01/2016 - 12/2003
2	Interferon-alpha (Interferon Alfa)IBA 12/2012 - 12/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 07/2011
2	Interleukin-15 (Interleukin 15)IBA 07/2011 - 12/2003
2	LigandsIBA 08/2005 - 07/2003
1	NucleoproteinsIBA 01/2022
1	Intergenic DNA (Junk DNA)IBA 01/2022
1	NeopterinIBA 11/2021
1	ChemokinesIBA 10/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2019
1	Immunoglobulin G (IgG)IBA 10/2019
1	CC ChemokinesIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2019
1	idelalisibIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 12/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2016
1	EpitopesIBA 11/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Cell Adhesion Molecule-1IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 12/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2015
1	Heroin (Diamorphine)IBA 07/2014
1	Estriol (Epiestriol)IBA 02/2014
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 09/2013
1	ChromatinIBA 03/2013
1	Daclizumab (Zenapax)FDA Link 07/2012
1	ProteomeIBA 10/2011
1	Treponema pallidum 47-kDa immunogenIBA 10/2011
1	Lipoproteins (Lipoprotein)IBA 10/2011

Therapy/Procedure

17	Therapeutics 12/2022 - 09/2005
3	Drug Therapy (Chemotherapy) 01/2019 - 12/2011
2	Transplantation 03/2018 - 01/2016
2	Highly Active Antiretroviral Therapy (HAART) 03/2014 - 01/2002
1	Art Therapy 10/2019
1	Immunotherapy 01/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Cesarean Section (Caesarean Section) 01/2019
1	Organ Transplantation 03/2018
1	Analgesia 01/2016